INTRODUCTION: Every year, health expenditure in Spain increases and, with it, the resources dedicated to cancer treatment. Cutaneous melanoma is the skin cancer with the highest morbidity and mortality. OBJECTIVES: We performed a descriptive study of the costs, based on a theoretical model, to determine the healthcare expenditure for patients with cutaneous melanoma; the objective was to define the overall costs (direct and indirect) of the diagnostic and treatment process of cutaneous melanoma, divided into different stages or diagnostic-therapeutic steps, and the possible variations in these costs. MATERIAL AND METHODS: For this purpose, we used the Andalusian analytical accountancy program of hospitals and districts (COAN-hyd) and the total costs module of the COAN for 2007, applied to the protocol we use in the melanoma unit of our hospital. CONCLUSIONS: The most important conclusions were that the greatest health care expenditure was observed inpatients with more advanced melanomas, with a poor prognosis. Management of the diagnostic-therapeutic process by dermatologists, the appropriate use of complementary tests, and operations performed by dermatologists reduce costs.
INTRODUCTION: Every year, health expenditure in Spain increases and, with it, the resources dedicated to cancer treatment. Cutaneous melanoma is the skin cancer with the highest morbidity and mortality. OBJECTIVES: We performed a descriptive study of the costs, based on a theoretical model, to determine the healthcare expenditure for patients with cutaneous melanoma; the objective was to define the overall costs (direct and indirect) of the diagnostic and treatment process of cutaneous melanoma, divided into different stages or diagnostic-therapeutic steps, and the possible variations in these costs. MATERIAL AND METHODS: For this purpose, we used the Andalusian analytical accountancy program of hospitals and districts (COAN-hyd) and the total costs module of the COAN for 2007, applied to the protocol we use in the melanoma unit of our hospital. CONCLUSIONS: The most important conclusions were that the greatest health care expenditure was observed inpatients with more advanced melanomas, with a poor prognosis. Management of the diagnostic-therapeutic process by dermatologists, the appropriate use of complementary tests, and operations performed by dermatologists reduce costs.
Authors: Grant A McArthur; Peter Mohr; Paolo Antonio Ascierto; Ana Arance; Ana Banos Hernaez; Peter Kaskel; Michael Weichenthal; Reshma Shinde; Kendall Stevinson Journal: Oncologist Date: 2017-05-19
Authors: Ahmad Tarhini; Sameer R Ghate; Raluca Ionescu-Ittu; Ameur M Manceur; Briana Ndife; Philippe Jacques; François Laliberté; Antonio Nakasato; Rebecca Burne; Mei Sheng Duh Journal: Melanoma Res Date: 2018-12 Impact factor: 3.599
Authors: Michele Maio; Paolo Ascierto; Alessandro Testori; Ruggero Ridolfi; Emilio Bajetta; Paola Queirolo; Michele Guida; Antonella Romanini; Vanna Chiarion-Sileni; Jacopo Pigozzo; Anna Maria Di Giacomo; Mario Calandriello; Guido Didoni; Marck van Baardewijk; Cyril Konto; Carlo Lucioni Journal: J Exp Clin Cancer Res Date: 2012-11-01
Authors: Francesco M Solivetti; Fulvia Elia; Antonino Guerrisi; Flora Desiderio; Maria Santaguida; Isabella Sperduti; Claudia Cavallotti; Aldo Di Carlo Journal: J Exp Clin Cancer Res Date: 2013-10-09